We are live on
!
Find out more
BCM
Bluefin Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
18.42%
This Fund
S&P 500
This Quarter
Est. Return
+4.49%
1 Year Est. Return
+18.42%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
+$11.5M
(+1.2%)
Cap. Flow
+$1.03B
Cap. Flow
% of AUM
102.56%
Top 10 Holdings %
Top 10 Hldgs %
47.49%
Holding
702
New
252
Increased
126
Reduced
88
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$102M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$35.6M |
| 3 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$32.3M |
| 4 |
WY.PRA
WEYERHAEUSER COMP PREF CONV SER A (WA)
WY.PRA
|
+$29.7M |
| 5 |
PNK
Pinnacle Entertainment Inc.
PNK
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$71.9M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$38M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$24M |
| 4 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$18.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.06% |
| 2 | Energy | 7.43% |
| 3 | Materials | 7.26% |
| 4 | Technology | 6.51% |
| 5 | Financials | 3.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $17K | ﹤0.01% |
112,200
+32,200
| +40% | +$2.68M |
|
402
CALL
Kinder Morgan
KMI
$69.7B
| $17K | ﹤0.01% |
959,900
-68,800
| -7% | -$1.23M |
|
403
PUT
Microsoft
MSFT
$3.71T
| $17K | ﹤0.01% |
+196,800
| New | +$10.2M |
|
|
X
404
CALL
DELISTED
US Steel
X
| $17K | ﹤0.01% |
10,000
-44,000
| -81% | -$739K |
|
|
SEP
405
PUT
DELISTED
Spectra Engy Parters Lp
SEP
| $17K | ﹤0.01% |
+60,000
| New | +$2.82M |
|
406
PUT
Alibaba
BABA
$304B
| $16K | ﹤0.01% |
10,000
| – | – |
|
407
CALL
Verizon
VZ
$195B
| $16K | ﹤0.01% |
16,200
-73,800
| -82% | -$3.83M |
|
408
CALL
CVS Health
CVS
$123B
| $15K | ﹤0.01% |
+15,200
| New | +$1.51M |
|
409
CALL
Euronet Worldwide
EEFT
$2.73B
| $15K | ﹤0.01% |
32,500
+5,500
| +20% | +$419K |
|
410
CALL
JD.com
JD
$44.3B
| $15K | ﹤0.01% |
+41,500
| New | +$1M |
|
411
PUT
United Airlines
UAL
$41.9B
| $15K | ﹤0.01% |
10,000
-20,800
| -68% | -$984K |
|
412
PUT
Oracle
ORCL
$413B
| $14K | ﹤0.01% |
+71,900
| New | +$2.87M |
|
413
PUT
UnitedHealth
UNH
$367B
| $14K | ﹤0.01% |
+54,500
| New | +$7.27M |
|
414
CALL
Delta Air Lines
DAL
$60.5B
| $13K | ﹤0.01% |
+13,600
| New | +$578K |
|
415
CALL
Delek US
DK
$3.59B
| $13K | ﹤0.01% |
+100,000
| New | +$1.42M |
|
416
PUT
Franco-Nevada
FNV
$44.6B
| $13K | ﹤0.01% |
100,400
-50,000
| -33% | -$3.38M |
|
|
HAPN
417
PUT
Happen Inc
HAPN
$2.27B
| $13K | ﹤0.01% |
+17,760
| New | +$512K |
|
418
PUT
Morgan Stanley
MS
$336B
| $13K | ﹤0.01% |
76,100
+52,600
| +224% | +$1.38M |
|
419
PUT
Spectrum Brands
SPB
$2.03B
| $13K | ﹤0.01% |
20,000
| – | – |
|
420
CALL
Vipshop
VIPS
$7.4B
| $13K | ﹤0.01% |
15,000
-270,000
| -95% | -$3.3M |
|
|
DRII
421
CALL
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $13K | ﹤0.01% |
+25,000
| New | +$566K |
|
422
CALL
Chevron
CVX
$371B
| $12K | ﹤0.01% |
22,000
+10,600
| +93% | +$1.07M |
|
423
PUT
ExxonMobil
XOM
$642B
| $12K | ﹤0.01% |
+126,100
| New | +$11.1M |
|
424
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.52B
| $12K | ﹤0.01% |
8,575
-28,250
| -77% | -$3.88M |
|
|
SPLK
425
PUT
DELISTED
Splunk Inc
SPLK
| $12K | ﹤0.01% |
+10,000
| New | +$528K |
|
Similar funds
PMSA
CFG
BCM
BWM
MCA
HAM
SPM
DWM
Bluefin Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Bluefin Capital Management held 702 positions worth $1.01B, up 1.2% from $995M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Bluefin Capital Management deployed $1.03B of net new capital in Q2 2016, opening 252 new positions and adding to 126 existing holdings. Its largest new stake was Allergan plc: 443,994 shares worth $103M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.9% a quarter earlier, followed by Energy and Materials.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $38M trimmed.
- Bluefin Capital Management's largest Q2 2016 buy was Allergan plc: 443,994 shares worth $103M.
- Bluefin Capital Management added most to EMC CORPORATION in Q2 2016, an estimated $17.8M increase.
- Bluefin Capital Management's biggest Q2 2016 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $38M.
- Bluefin Capital Management fully exited Baxter International in Q2 2016, selling an estimated $71.9M.
- Bluefin Capital Management's ten largest holdings make up 47% of its $1.01B portfolio in Q2 2016.
- Bluefin Capital Management opened 252 new positions and closed 204 in Q2 2016.
- Bluefin Capital Management's portfolio value rose 1.2% quarter-over-quarter to $1.01B.
Based on Bluefin Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.